Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.79K Buy
+52
New +$7.18K 0.01% 368
2025
Q3
– Sell
-454
Closed -$35.9K – 769
2025
Q2
$35.9K Sell
454
-61
-12% -$4.85K 0.02% 344
2025
Q1
$46.2K Sell
515
-444
-46% -$41.5K 0.02% 290
2024
Q4
$95.4K Buy
+959
New +$98.9K 0.03% 269

Other funds holding MRK

Transce3nd's MRK Position: Q3 2026 in Review

Transce3nd opened a new position in Merck (MRK) in Q3 2026: 52 shares worth $7.79K. The stake represents 0.01% of the portfolio and ranks #368 among its holdings. This is a return to the name: Transce3nd previously reported a position in MRK as recently as Q2 2025.

Transce3nd first reported a position in MRK in Q4 2024 and has held it in 4 quarters since. The position peaked at $95.4K in Q4 2024. 3,967 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Transce3nd held 52 shares of Merck worth $7.79K as of Q3 2026.
  • Merck was a new Transce3nd position in Q3 2026.
  • Merck made up 0.01% of Transce3nd's portfolio in Q3 2026, its #368 holding.
  • Transce3nd first reported a position in Merck in Q4 2024 and has held it in 4 quarters since.
  • Transce3nd's Merck position peaked at $95.4K in Q4 2024.
  • 3,967 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Transce3nd's 13F filing for Q3 2026, filed 26 Oct 2026.